A new Center of Excellence will be established at PCI Pharma Services’ location in Rockford, Ill., and two sites in Ireland will also benefit from the investment. PCI Pharma Services, a Philadelphia-based contract development and manufacturing organization (CDMO), announced in a press release on Sept. 24, 2024 that it was investing in excess of $365 million in a number of new or existing facilities, including its Biotech Center of Excellence in Philadelphia, a campus in Rockford, Ill., and a new acquisition and groundbreaking, both in Dublin, Ireland (1).